Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
HIV Medicine
|
August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients
S M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Alimentary Pharmacology & Therapeutics
|
March 15, 2018
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection
J von Felden, J Vermehren, P Ingiliz, et al.
Journal of Viral Hepatitis
|
March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry
T M Welzel, H Hinrichsen, C Sarrazin, et al.
Infection
|
September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
J Thoden, A Potthoff, J R Bogner, et al.
European Journal of Medical Research
|
August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort
C Koegl, E Wolf, N Hanhoff, et al.
Journal of Viral Hepatitis
|
April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis
|
April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis
|
April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, A S Duberg, M Buti, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
HIV Medicine
|
August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients
S M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Alimentary Pharmacology & Therapeutics
|
March 15, 2018
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection
J von Felden, J Vermehren, P Ingiliz, et al.
Journal of Viral Hepatitis
|
March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C Registry
T M Welzel, H Hinrichsen, C Sarrazin, et al.
Infection
|
September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
J Thoden, A Potthoff, J R Bogner, et al.
European Journal of Medical Research
|
August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort
C Koegl, E Wolf, N Hanhoff, et al.
Journal of Viral Hepatitis
|
April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countries
P Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis
|
April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis
|
April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burden
H Wedemeyer, A S Duberg, M Buti, et al.
Page
of 9